RUNX1 and acute lymphoblastic leukemia: RUNX1 occupied 27 786 sites genome-wide in BCP-ALL patients, 5 514 sites in Nalm6 cells with an overlap of 69% between Nalm6 and patients’ cells [26], 9 621 sites in REH cells with an overlap of 60% with Nalm6 and 65% with patients (Additional file 2: Fig. S1B).